Emerging role of ISG15 in antiviral immunity - PubMed (original) (raw)
Review
Emerging role of ISG15 in antiviral immunity
Brian Skaug et al. Cell. 2010.
Abstract
Cells express a plethora of interferon-stimulated genes (ISGs) in response to viral infection. Among these is ISG15, a ubiquitin-like protein (UBL) that can be covalently attached to both host and viral proteins. Here we review recent advances toward understanding the role and mechanism of ISG15 modification in antiviral defense.
Copyright © 2010 Elsevier Inc. All rights reserved.
Figures
Figure 1. ISGylation and Its Antiviral Mechanisms
A. ISG15, like ubiquitin, is attached to substrates in a three-step enzymatic cascade. In the first step, ISG15 is “activated” by UBE1L in an ATP-dependent process. ISG15 is then transferred to the E2 UBCH8, and subsequently to a target protein through the E3 HERC5. Like ubiquitin, ISG15 is conjugated to a lysine on the target protein through a C-terminal glycine-glycine motif. B. Type I interferons (IFNs) induce expression of ISG15 and ISGylation machinery including HERC5. During infection with influenza A, nonstructural protein 1 (NS1A) protein is ISGylated on lysine 41. ISGylation inhibits the binding of NS1A to the nuclear import factor importin-α. Mutation of this lysine largely protects influenza A from the antiviral actions of type I IFN. C. HERC5, likely due to its association with ribosomes, broadly targets newly-synthesized proteins for ISGylation. ISGylation of certain viral proteins, including those that make up the capsid, could have a dominant negative effect by interfering with the precise assembly of higher order structures. Thus ISG15 can cause a significant impairment in viral infectivity despite ISGylation of only a small percentage of the target proteins.
Similar articles
- ISG15 in antiviral immunity and beyond.
Perng YC, Lenschow DJ. Perng YC, et al. Nat Rev Microbiol. 2018 Jul;16(7):423-439. doi: 10.1038/s41579-018-0020-5. Nat Rev Microbiol. 2018. PMID: 29769653 Free PMC article. Review. - HERC5 and the ISGylation Pathway: Critical Modulators of the Antiviral Immune Response.
Mathieu NA, Paparisto E, Barr SD, Spratt DE. Mathieu NA, et al. Viruses. 2021 Jun 9;13(6):1102. doi: 10.3390/v13061102. Viruses. 2021. PMID: 34207696 Free PMC article. Review. - [Advances in ubiquitin-like protein ISG15-mediated anti-viral response].
Zhu ZX, Wei JC, Shi ZX, Wu KB, Ma ZY. Zhu ZX, et al. Bing Du Xue Bao. 2012 Jan;28(1):78-83. Bing Du Xue Bao. 2012. PMID: 22416355 Review. Chinese. - ISG15 deficiency and increased viral resistance in humans but not mice.
Speer SD, Li Z, Buta S, Payelle-Brogard B, Qian L, Vigant F, Rubino E, Gardner TJ, Wedeking T, Hermann M, Duehr J, Sanal O, Tezcan I, Mansouri N, Tabarsi P, Mansouri D, Francois-Newton V, Daussy CF, Rodriguez MR, Lenschow DJ, Freiberg AN, Tortorella D, Piehler J, Lee B, García-Sastre A, Pellegrini S, Bogunovic D. Speer SD, et al. Nat Commun. 2016 May 19;7:11496. doi: 10.1038/ncomms11496. Nat Commun. 2016. PMID: 27193971 Free PMC article. - ISG15: In Sickness and in Health.
Hermann M, Bogunovic D. Hermann M, et al. Trends Immunol. 2017 Feb;38(2):79-93. doi: 10.1016/j.it.2016.11.001. Epub 2016 Nov 22. Trends Immunol. 2017. PMID: 27887993 Review.
Cited by
- The role of ubiquitination in health and disease.
Liao Y, Zhang W, Liu Y, Zhu C, Zou Z. Liao Y, et al. MedComm (2020). 2024 Sep 25;5(10):e736. doi: 10.1002/mco2.736. eCollection 2024 Oct. MedComm (2020). 2024. PMID: 39329019 Free PMC article. Review. - Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape.
Wu X, Go M, Nguyen JV, Kuchel NW, Lu BGC, Zeglinski K, Lowes KN, Calleja DJ, Mitchell JP, Lessene G, Komander D, Call ME, Call MJ. Wu X, et al. Nat Commun. 2024 Jul 23;15(1):6219. doi: 10.1038/s41467-024-50566-9. Nat Commun. 2024. PMID: 39043718 Free PMC article. - ISG15/USP18/STAT2 is a molecular hub regulating IFN I-mediated control of Dengue and Zika virus replication.
Espada CE, da Rocha EL, Ricciardi-Jorge T, Dos Santos AA, Soares ZG, Malaquias G, Patrício DO, Gonzalez Kozlova E, Dos Santos PF, Bordignon J, Sanford TJ, Fajardo T, Sweeney TR, Báfica A, Mansur DS. Espada CE, et al. Front Immunol. 2024 Feb 7;15:1331731. doi: 10.3389/fimmu.2024.1331731. eCollection 2024. Front Immunol. 2024. PMID: 38384473 Free PMC article. - Dynamic RBM47 ISGylation confers broad immunoprotection against lung injury and tumorigenesis via TSC22D3 downregulation.
Ding S, Pang X, Luo S, Gao H, Li B, Yue J, Chen J, Hu S, Tu Z, He D, Kuang Y, Dong Z, Zhang M. Ding S, et al. Cell Death Discov. 2023 Nov 30;9(1):430. doi: 10.1038/s41420-023-01736-z. Cell Death Discov. 2023. PMID: 38036512 Free PMC article. - Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo.
Tursi NJ, Xu Z, Helble M, Walker S, Liaw K, Chokkalingam N, Kannan T, Wu Y, Tello-Ruiz E, Park DH, Zhu X, Wise MC, Smith TRF, Majumdar S, Kossenkov A, Kulp DW, Weiner DB. Tursi NJ, et al. Front Immunol. 2023 Feb 23;14:1072810. doi: 10.3389/fimmu.2023.1072810. eCollection 2023. Front Immunol. 2023. PMID: 36911698 Free PMC article.
References
- Chang YG, Yan XZ, Xie YY, Gao XC, Song AX, Zhang DE, Hu HY. J Biol Chem. 2008;283:13370–13377. - PubMed
- Desai SD, Haas AL, Wood LM, Tsai YC, Pestka S, Rubin EH, Saleem A, Nur EKA, Liu LF. Cancer Res. 2006;66:921–928. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous